Therefore, the haloperidol-treated schizophrenia patients were grouped according to the combined presence of HTR6 T and SLC6A3 9R alleles, which were identified as risk alleles for AIP. This evidence concerns the gene SLC6A3 and autoimmune pancreatitis.